What is the current annual EBITDA of DVA?

As of today, DVA annual EBITDA is $2.73B

What is 1-year change in DVA annual EBITDA?

DVA annual EBITDA is up +1.76% year-over-year

What is 3-year change in DVA annual EBITDA?

DVA annual EBITDA is up +33.29% over the past 3 years

How far is DVA annual EBITDA from its all-time high?

DVA annual EBITDA is currently at its all-time high

How does DVA annual EBITDA rank versus sector peers?

DVA annual EBITDA is higher than 96.03% of companies in Healthcare sector

When is DVA next annual earnings release?

As of today, the next annual earnings release for DVA has not been scheduled

What is the current quarterly EBITDA of DVA?

As of today, DVA quarterly EBITDA is $738.63M

What is DVA quarterly EBITDA most recent change?

DVA quarterly EBITDA was up +13.39% on June 30, 2026

What is 1-year change in DVA quarterly EBITDA?

DVA quarterly EBITDA is up +4.74% year-over-year

How far is DVA quarterly EBITDA from its all-time high?

DVA quarterly EBITDA is currently at its all-time high

How does DVA quarterly EBITDA rank versus sector peers?

DVA quarterly EBITDA is higher than 96.01% of companies in Healthcare sector

When is DVA next earnings release?

The next earnings release for DVA is on October 28, 2026

What is the current TTM EBITDA of DVA?

As of today, DVA TTM EBITDA is $2.80B

What is DVA TTM EBITDA most recent change?

DVA TTM EBITDA was up +1.21% on June 30, 2026

What is 1-year change in DVA TTM EBITDA?

DVA TTM EBITDA is up +4.21% year-over-year

How far is DVA TTM EBITDA from its all-time high?

DVA TTM EBITDA is currently at its all-time high

How does DVA TTM EBITDA rank versus sector peers?

DVA TTM EBITDA is higher than 96.01% of companies in Healthcare sector

When is DVA next earnings release?

The next earnings release for DVA is on October 28, 2026

DaVita Inc. (DVA) EBITDA History & Chart Since 1994

Annual EBITDA

$2.73B$47.28M+1.76%

December 31, 2025

Summary

Current Value: As of today, DVA annual EBITDA is $2.73B, up +1.76% on December 31, 2025
Historical Performance: DVA annual EBITDA is up +33.29% over the past 3 years, up +17.78% over the past 5 years
All-Time High Comparison: DVA annual EBITDA is currently at its all-time high
3-Year Low Comparison: DVA annual EBITDA is +33.29% above its 3-year low of $2.05B reached on an earlier date
Sector Comparison: DVA annual EBITDA is higher than 96.03% of companies in Healthcare sector

EBITDA Chart

beforeafter

Performance

DVA Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual EBITDA	Dec 31, 25	$2.73B	+1.8%	+33.3%	+17.8%	+123.0%
Quarterly EBITDA	Jun 30, 26	$738.63M	+4.7%	+27.2%	+13.1%	+121.7%
TTM EBITDA	Jun 30, 26	$2.80B	+4.2%	+39.4%	+17.4%	+123.0%
Price	Aug 18, 26	$177.91	+33.5%	+75.2%	+35.9%	+404.1%
PE Ratio	Aug 18, 26	15.00	+14.6%	-27.8%	-12.1%	-18.4%
Annual Revenue	Dec 31, 25	$13.64B	+6.5%	+17.5%	+18.1%	+111.6%
Annual EPS	Dec 31, 25	$9.51	-11.3%	+66.7%	+48.9%	+382.8%
	Dec 31, 25	$2.01B	+2.9%	+53.2%	+19.4%	+103.5%
Annual Net Income	Dec 31, 25	$1.05B	-15.8%	+37.2%	+4.9%	+117.6%

EBITDA Highs

DVA Annual EBITDA Highs Comparison
Period	High	Date	Current
3Y	$2.73B	Dec 31, 25	at high
5Y	$2.73B	Dec 31, 25	at high
All	$2.73B	Dec 31, 25	at high

EBITDA Lows

DVA Annual EBITDA Lows Comparison
Period	Low	Date	Current
3Y	$2.05B	N/A	+33.3%
5Y	$2.05B	Dec 31, 22	+33.3%
All	$21.90M	May 1, 95	>+9999.0%

EBITDA History

Year	Value	Change
2025	$2.73B	+1.8%
2024	$2.68B	+14.2%
2023	$2.35B	+14.7%
2022	$2.05B	-16.6%
2021	$2.45B	+5.9%
2020	$2.31B	-2.4%
2019	$2.37B	+13.3%
2018	$2.09B	-4.1%
2017	$2.18B	-0.4%
2016	$2.19B	-12.2%
2015	$2.50B	+4.0%
2014	$2.40B	+0.7%
2013	$2.38B	+39.6%
2012	$1.71B	+19.1%
2011	$1.43B	+17.4%
2010	$1.22B	+4.8%

Year	Value	Change
2009	$1.17B	+7.5%
2008	$1.09B	+3.8%
2007	$1.05B	+14.9%
2006	$910.59M	+50.7%
2005	$604.30M	+26.9%
2004	$476.29M	+3.4%
2003	$460.53M	+1.1%
2002	$455.62M	+7.7%
2001	$423.20M	+45.5%
2000	$290.88M	+54.5%
1999	$188.30M	-39.7%
1998	$312.03M	+191.7%
1997	$106.98M	+66.6%
1996	$64.20M	+102.4%
1995	$31.71M	+44.8%
1995	$21.90M	-

FAQ

What is the current annual EBITDA of DVA?: As of today, DVA annual EBITDA is $2.73B
What is 1-year change in DVA annual EBITDA?: DVA annual EBITDA is up +1.76% year-over-year
What is 3-year change in DVA annual EBITDA?: DVA annual EBITDA is up +33.29% over the past 3 years
How far is DVA annual EBITDA from its all-time high?: DVA annual EBITDA is currently at its all-time high
How does DVA annual EBITDA rank versus sector peers?: DVA annual EBITDA is higher than 96.03% of companies in Healthcare sector
When is DVA next annual earnings release?: As of today, the next annual earnings release for DVA has not been scheduled

EBITDA Formula

EBITDA = Net Income + + +

Quarterly EBITDA

$738.63M$87.25M+13.39%

June 30, 2026

Summary

Current Value: As of today, DVA quarterly EBITDA is $738.63M, up +13.39% on June 30, 2026
Historical Performance: DVA quarterly EBITDA is up +4.74% year-over-year, up +27.24% over the past 3 years
All-Time High Comparison: DVA quarterly EBITDA is currently at its all-time high
3-Year Low Comparison: DVA quarterly EBITDA is +27.24% above its 3-year low of $580.51M reached on an earlier date
Sector Comparison: DVA quarterly EBITDA is higher than 96.01% of companies in Healthcare sector

Performance

DVA Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly EBITDA	Jun 30, 26	$738.63M	+13.4%	+4.7%	+27.2%	+13.1%
Annual EBITDA	Dec 31, 25	$2.73B	–	+1.8%	+33.3%	+17.8%
TTM EBITDA	Jun 30, 26	$2.80B	+1.2%	+4.2%	+39.4%	+17.4%
Price	Aug 18, 26	$177.91	-10.8%	+33.5%	+75.2%	+35.9%
PE Ratio	Aug 18, 26	15.00	-21.7%	+14.6%	-27.8%	-12.1%
Quarterly Revenue	Jun 30, 26	$3.55B	+4.1%	+5.2%	+18.4%	+21.9%
Quarterly EPS	Jun 30, 26	$4.02	+40.0%	+55.8%	+109.9%	+52.3%
	Jun 30, 26	$570.82M	+20.5%	+7.6%	+43.8%	+18.1%
Quarterly Net Income	Jun 30, 26	$343.22M	+24.8%	+24.7%	+39.3%	-2.2%

Quarterly EBITDA Highs

DVA Quarterly EBITDA Highs Comparison
Period	High	Date	Current
1Y	$738.63M	Jun 30, 26	at high
3Y	$738.63M	Jun 30, 26	at high
5Y	$738.63M	Jun 30, 26	at high
All	$738.63M	Jun 30, 26	at high

Quarterly EBITDA Lows

DVA Quarterly EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$651.38M	Mar 31, 26	+13.4%
3Y	$580.51M	N/A	+27.2%
5Y	$448.50M	Dec 31, 22	+64.7%
All	-$57.00M	May 31, 95	+1395.8%

Quarterly EBITDA History

Month	Value	Change
Jun 2026	$738.63M	+13.4%
Mar 2026	$651.38M	-11.7%
Dec 2025	$737.91M	+9.6%
Sep 2025	$673.10M	-4.6%
Jun 2025	$705.18M	+15.6%
Mar 2025	$609.78M	-6.9%
Dec 2024	$654.83M	-8.8%
Sep 2024	$718.18M	+6.1%
Jun 2024	$676.58M	+7.5%
Mar 2024	$629.10M	+3.8%
Dec 2023	$605.91M	-10.5%
Sep 2023	$677.13M	+16.6%
Jun 2023	$580.51M	+20.2%
Mar 2023	$482.90M	+7.7%
Dec 2022	$448.50M	-9.9%
Sep 2022	$497.69M	-16.3%
Jun 2022	$594.75M	+18.0%
Mar 2022	$504.21M	-10.1%
Dec 2021	$561.03M	-11.9%
Sep 2021	$636.64M	-2.5%
Jun 2021	$653.14M	+8.8%
Mar 2021	$600.25M	+10.4%
Dec 2020	$543.92M	-7.7%
Sep 2020	$589.07M	+1.7%
Jun 2020	$579.21M	-3.8%
Mar 2020	$602.21M	-2.8%
Dec 2019	$619.53M	+0.9%
Sep 2019	$614.17M	+0.7%
Jun 2019	$609.61M	+15.6%
Mar 2019	$527.36M	+0.4%
Dec 2018	$525.52M	+17.7%
Sep 2018	$446.46M	-19.7%
Jun 2018	$555.87M	+0.5%
Mar 2018	$553.33M	-4.5%
Dec 2017	$579.45M	+6.7%
Sep 2017	$543.24M	+0.1%
Jun 2017	$542.55M	+5.5%
Mar 2017	$514.40M	-15.1%
Dec 2016	$605.69M	-2.7%
Sep 2016	$622.28M	-5.2%
Jun 2016	$656.17M	+7.6%
Mar 2016	$609.86M	+0.5%
Dec 2015	$606.83M	-9.2%
Sep 2015	$668.65M	+5.4%
Jun 2015	$634.36M	+9.0%
Mar 2015	$581.73M	-3.2%
Dec 2014	$600.80M	+0.4%
Sep 2014	$598.51M	-4.1%
Jun 2014	$624.11M	+8.3%
Mar 2014	$576.43M	-6.3%
Dec 2013	$615.33M	+3.0%
Sep 2013	$597.62M	+1.6%
Jun 2013	$587.98M	+0.8%
Mar 2013	$583.40M	+17.9%
Dec 2012	$495.00M	+18.3%
Sep 2012	$418.38M	+4.3%
Jun 2012	$401.07M	+1.8%
Mar 2012	$394.06M	-4.8%
Dec 2011	$413.88M	+5.4%
Sep 2011	$392.65M	+17.9%
Jun 2011	$333.10M	+12.5%
Mar 2011	$296.07M	-5.5%
Dec 2010	$313.45M	+0.1%
Sep 2010	$313.29M	+5.2%

Month	Value	Change
Jun 2010	$297.88M	+0.0%
Mar 2010	$297.79M	+1.2%
Dec 2009	$294.20M	-2.3%
Sep 2009	$301.11M	+2.5%
Jun 2009	$293.76M	+5.8%
Mar 2009	$277.75M	-0.5%
Dec 2008	$279.21M	+1.3%
Sep 2008	$275.57M	+1.6%
Jun 2008	$271.32M	+4.7%
Mar 2008	$259.12M	+0.7%
Dec 2007	$257.38M	-5.9%
Sep 2007	$273.44M	+3.0%
Jun 2007	$265.35M	+6.3%
Mar 2007	$249.73M	+2.9%
Dec 2006	$242.70M	+3.5%
Sep 2006	$234.56M	+5.6%
Jun 2006	$222.17M	+5.2%
Mar 2006	$211.17M	+16.6%
Dec 2005	$181.16M	+24.1%
Sep 2005	$145.97M	+14.6%
Jun 2005	$127.36M	+3.8%
Mar 2005	$122.71M	+2.0%
Dec 2004	$120.32M	-10.1%
Sep 2004	$133.91M	+10.8%
Jun 2004	$120.90M	+0.9%
Mar 2004	$119.82M	-15.1%
Dec 2003	$141.18M	+23.2%
Sep 2003	$114.55M	+13.7%
Jun 2003	$100.72M	+2.7%
Mar 2003	$98.07M	-28.5%
Dec 2002	$137.07M	+7.4%
Sep 2002	$127.59M	+35.4%
Jun 2002	$94.22M	-0.5%
Mar 2002	$94.72M	-6.6%
Dec 2001	$101.38M	-17.7%
Sep 2001	$123.15M	+27.4%
Jun 2001	$96.68M	+3.5%
Mar 2001	$93.43M	+18.1%
Dec 2000	$79.08M	+2.9%
Sep 2000	$76.83M	+14.8%
Jun 2000	$66.93M	-1.6%
Mar 2000	$68.04M	>+9,900.0%
Dec 1999	-$383.00K	-100.6%
Sep 1999	$66.48M	+207.5%
Jun 1999	$21.62M	-77.7%
Mar 1999	$96.95M	+38.5%
Dec 1998	$70.02M	-23.5%
Sep 1998	$91.49M	+13.3%
Jun 1998	$80.74M	+15.7%
Mar 1998	$69.78M	+71.9%
Dec 1997	$40.60M	-31.6%
Sep 1997	$59.40M	+136.7%
Jun 1997	$25.10M	+17.8%
Mar 1997	$21.30M	-65.1%
Dec 1996	$61.10M	+251.1%
Sep 1996	$17.40M	+14.5%
Jun 1996	$15.20M	+26.7%
Mar 1996	$12.00M	+15.4%
Nov 1995	$10.40M	+13.0%
Aug 1995	$9.20M	+116.1%
May 1995	-$57.00M	-329.8%
Feb 1995	$24.80M	+0.4%
Nov 1994	$24.70M	0.0%
Aug 1994	$24.70M	-

FAQ

What is the current quarterly EBITDA of DVA?: As of today, DVA quarterly EBITDA is $738.63M
What is DVA quarterly EBITDA most recent change?: DVA quarterly EBITDA was up +13.39% on June 30, 2026
What is 1-year change in DVA quarterly EBITDA?: DVA quarterly EBITDA is up +4.74% year-over-year
How far is DVA quarterly EBITDA from its all-time high?: DVA quarterly EBITDA is currently at its all-time high
How does DVA quarterly EBITDA rank versus sector peers?: DVA quarterly EBITDA is higher than 96.01% of companies in Healthcare sector
When is DVA next earnings release?: The next earnings release for DVA is on October 28, 2026

EBITDA Formula

EBITDA = Net Income + + +

TTM EBITDA

$2.80B$33.44M+1.21%

June 30, 2026

Summary

Current Value: As of today, DVA TTM EBITDA is $2.80B, up +1.21% on June 30, 2026
Historical Performance: DVA TTM EBITDA is up +4.21% year-over-year, up +39.38% over the past 3 years
All-Time High Comparison: DVA TTM EBITDA is currently at its all-time high
3-Year Low Comparison: DVA TTM EBITDA is +39.38% above its 3-year low of $2.01B reached on an earlier date
Sector Comparison: DVA TTM EBITDA is higher than 96.01% of companies in Healthcare sector

Performance

DVA Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM EBITDA	Jun 30, 26	$2.80B	+1.2%	+4.2%	+39.4%	+17.4%
Annual EBITDA	Dec 31, 25	$2.73B	–	+1.8%	+33.3%	+17.8%
Quarterly EBITDA	Jun 30, 26	$738.63M	+13.4%	+4.7%	+27.2%	+13.1%
Price	Aug 18, 26	$177.91	-10.8%	+33.5%	+75.2%	+35.9%
PE Ratio	Aug 18, 26	15.00	-21.7%	+14.6%	-27.8%	-12.1%
TTM Revenue	Jun 30, 26	$14.01B	+1.3%	+6.5%	+19.4%	+21.1%
TTM EPS	Jun 30, 26	$11.86	+13.8%	+16.5%	+142.7%	+54.6%
	Jun 30, 26	$2.09B	+2.0%	+5.8%	+66.0%	+20.7%
TTM Net Income	Jun 30, 26	$1.16B	+6.2%	+1.1%	+67.6%	+4.5%

TTM EBITDA Highs

DVA TTM EBITDA Highs Comparison
Period	High	Date	Current
1Y	$2.80B	Jun 30, 26	at high
3Y	$2.80B	Jun 30, 26	at high
5Y	$2.80B	Jun 30, 26	at high
All	$2.80B	Jun 30, 26	at high

TTM EBITDA Lows

DVA TTM EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$2.64B	Sep 30, 25	+6.0%
3Y	$2.01B	N/A	+39.4%
5Y	$2.01B	Jun 30, 23	+39.4%
All	-$25.40M	Mar 31, 96	>+9999.0%

TTM EBITDA History

Month	Value	Change
Jun 2026	$2.80B	+1.2%
Mar 2026	$2.77B	+1.5%
Dec 2025	$2.73B	+3.1%
Sep 2025	$2.64B	-1.7%
Jun 2025	$2.69B	+1.1%
Mar 2025	$2.66B	-0.7%
Dec 2024	$2.68B	+1.9%
Sep 2024	$2.63B	+1.6%
Jun 2024	$2.59B	+3.9%
Mar 2024	$2.49B	+6.2%
Dec 2023	$2.35B	+7.2%
Sep 2023	$2.19B	+8.9%
Jun 2023	$2.01B	-0.7%
Mar 2023	$2.02B	-1.0%
Dec 2022	$2.05B	-5.2%
Sep 2022	$2.16B	-6.0%
Jun 2022	$2.30B	-2.5%
Mar 2022	$2.36B	-3.9%
Dec 2021	$2.45B	+0.7%
Sep 2021	$2.43B	+2.0%
Jun 2021	$2.39B	+3.2%
Mar 2021	$2.31B	-0.1%
Dec 2020	$2.31B	-3.2%
Sep 2020	$2.39B	-1.0%
Jun 2020	$2.42B	-1.2%
Mar 2020	$2.45B	+3.2%
Dec 2019	$2.37B	+4.1%
Sep 2019	$2.28B	+8.0%
Jun 2019	$2.11B	+2.6%
Mar 2019	$2.06B	-1.2%
Dec 2018	$2.08B	-2.5%
Sep 2018	$2.14B	-4.3%
Jun 2018	$2.23B	+0.6%
Mar 2018	$2.22B	+1.8%
Dec 2017	$2.18B	-1.2%
Sep 2017	$2.21B	-3.5%
Jun 2017	$2.28B	-4.7%
Mar 2017	$2.40B	-3.8%
Dec 2016	$2.49B	-0.0%
Sep 2016	$2.50B	-1.8%
Jun 2016	$2.54B	+0.9%
Mar 2016	$2.52B	+1.1%
Dec 2015	$2.49B	+0.2%
Sep 2015	$2.49B	+2.9%
Jun 2015	$2.42B	+0.4%
Mar 2015	$2.41B	+0.2%
Dec 2014	$2.40B	-0.6%
Sep 2014	$2.41B	+0.0%
Jun 2014	$2.41B	+1.5%
Mar 2014	$2.38B	-0.3%
Dec 2013	$2.38B	+5.3%
Sep 2013	$2.26B	+8.6%
Jun 2013	$2.08B	+9.8%
Mar 2013	$1.90B	+11.1%
Dec 2012	$1.71B	+5.0%
Sep 2012	$1.63B	+1.6%
Jun 2012	$1.60B	+4.4%
Mar 2012	$1.53B	+6.8%
Dec 2011	$1.44B	+7.5%
Sep 2011	$1.34B	+6.3%
Jun 2011	$1.26B	+2.9%
Mar 2011	$1.22B	-0.1%
Dec 2010	$1.22B	+1.6%
Sep 2010	$1.20B	+1.0%

Month	Value	Change
Jun 2010	$1.19B	+0.3%
Mar 2010	$1.19B	+1.7%
Dec 2009	$1.17B	+1.3%
Sep 2009	$1.15B	+2.3%
Jun 2009	$1.13B	+2.0%
Mar 2009	$1.10B	+1.7%
Dec 2008	$1.09B	+2.1%
Sep 2008	$1.06B	+0.2%
Jun 2008	$1.06B	+0.6%
Mar 2008	$1.06B	+0.9%
Dec 2007	$1.05B	+1.4%
Sep 2007	$1.03B	+3.9%
Jun 2007	$992.33M	+4.5%
Mar 2007	$949.15M	+4.2%
Dec 2006	$910.59M	+7.2%
Sep 2006	$849.06M	+11.6%
Jun 2006	$760.47M	+14.2%
Mar 2006	$665.67M	+15.3%
Dec 2005	$577.21M	+11.8%
Sep 2005	$516.36M	+2.4%
Jun 2005	$504.30M	+1.3%
Mar 2005	$497.83M	+0.6%
Dec 2004	$494.95M	-4.0%
Sep 2004	$515.80M	+3.9%
Jun 2004	$496.44M	+4.2%
Mar 2004	$476.26M	+4.8%
Dec 2003	$454.52M	+0.9%
Sep 2003	$450.42M	-2.8%
Jun 2003	$463.46M	+1.4%
Mar 2003	$456.96M	+0.7%
Dec 2002	$453.61M	+8.5%
Sep 2002	$417.92M	+1.1%
Jun 2002	$413.47M	-0.6%
Mar 2002	$415.93M	+0.3%
Dec 2001	$414.64M	+5.7%
Sep 2001	$392.34M	+13.4%
Jun 2001	$346.02M	+9.4%
Mar 2001	$316.27M	+8.7%
Dec 2000	$290.88M	+37.6%
Sep 2000	$211.41M	+5.2%
Jun 2000	$201.06M	+29.1%
Mar 2000	$155.74M	-15.7%
Dec 1999	$184.65M	-27.6%
Sep 1999	$255.06M	-8.9%
Jun 1999	$280.07M	-17.4%
Mar 1999	$339.20M	+8.7%
Dec 1998	$312.03M	+10.4%
Sep 1998	$282.61M	+12.8%
Jun 1998	$250.52M	+28.6%
Mar 1998	$194.88M	+33.1%
Dec 1997	$146.40M	-12.3%
Sep 1997	$166.90M	+33.6%
Jun 1997	$124.90M	+8.6%
Mar 1997	$115.00M	+8.8%
Dec 1996	$105.70M	+92.2%
Sep 1996	$55.00M	+17.5%
Jun 1996	$46.80M	+284.3%
Mar 1996	-$25.40M	-101.6%
Nov 1995	-$12.60M	-841.2%
Aug 1995	$1.70M	-90.1%
May 1995	$17.20M	-76.8%
Feb 1995	$74.20M	+50.2%
Nov 1994	$49.40M	+100.0%
Aug 1994	$24.70M	-

FAQ

What is the current TTM EBITDA of DVA?: As of today, DVA TTM EBITDA is $2.80B
What is DVA TTM EBITDA most recent change?: DVA TTM EBITDA was up +1.21% on June 30, 2026
What is 1-year change in DVA TTM EBITDA?: DVA TTM EBITDA is up +4.21% year-over-year
How far is DVA TTM EBITDA from its all-time high?: DVA TTM EBITDA is currently at its all-time high
How does DVA TTM EBITDA rank versus sector peers?: DVA TTM EBITDA is higher than 96.01% of companies in Healthcare sector
When is DVA next earnings release?: The next earnings release for DVA is on October 28, 2026

EBITDA Formula

EBITDA = Net Income + + +

Data Sources & References

DVA Official Website www.davita.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/927066/000092706626000004/0000927066-26-000004-index.htm
DVA Profile on Yahoo Finance finance.yahoo.com/quote/DVA
DVA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/dva